Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
19.85
+0.56 (2.90%)
Jan 21, 2025, 4:00 PM EST - Market closed
Cartesian Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Jan '25 Jan 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 511 | 107 | - | - |
| Enterprise Value | 306 | 123 | - | - |
| Last Close Price | 19.85 | 20.68 | - | - |
| PS Ratio | 5.07 | 4.11 | - | - |
| PB Ratio | 512.19 | -0.77 | - | - |
| EV/Sales Ratio | 6.39 | 4.75 | - | - |
| Debt / Equity Ratio | 19.48 | -0.08 | 0.40 | 0.18 |
| Debt / EBITDA Ratio | - | - | 2.01 | - |
| Asset Turnover | 0.21 | 0.11 | 1.26 | - |
| Quick Ratio | 10.51 | 1.26 | 5.76 | 6.38 |
| Current Ratio | 10.70 | 1.33 | 5.91 | 6.42 |
| Return on Equity (ROE) | -7029.26% | - | 70.21% | - |
| Return on Assets (ROA) | -10.95% | -19.75% | 10.35% | - |
| Return on Capital (ROIC) | -224.77% | -3022.09% | 12.98% | - |
| Earnings Yield | -55.30% | -205.34% | - | - |
| FCF Yield | -9.48% | -48.01% | - | - |
| Buyback Yield / Dilution | -6.33% | -27.59% | - |
| Total Shareholder Return | -6.33% | -27.59% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.